Literature DB >> 2413995

Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.

R J King, A I Coffer, J Gilbert, K Lewis, R Nash, R Millis, S Raju, R W Taylor.   

Abstract

A monoclonal antibody (D5) raised against affinity-purified cytosol estradiol receptor (REC) from human myometrium has been used to stain human tissues by means of an indirect immunoperoxidase method. Good staining was obtained with ethanol-, glutaraldehyde-, or Carnoy's-fixed material but not with formalin or Bouin's fixation. Cytoplasmic staining of human breast tumors exhibited a highly significant correlation (P less than 0.001) with REC assayed by conventional estradiol-binding assay provided that allowance was made for both staining intensity and cellularity of the tumor; no correlation existed with soluble progesterone receptor content. Both patient age and tumor differentiation influenced staining patterns in the same way as did REC content. Cultured REC-positive human breast tumor cell lines (MCF-7, ZR-75-1, and CA-2) showed positive staining as did cultured epithelium from human milk. Epithelia in normal breast and fibroadenoma exhibited variable staining that rarely reached the intensity seen in REC-positive tumor cells. The staining patterns of human normal endometrium, myometrium, fallopian tube, ectocervix, endocervix, and ovary and neoplastic endometrium and ovary are described. In every situation thus far examined only cytoplasmic staining has been observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413995

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Oestrogen receptors in conjunctival malignant melanoma.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.

Authors:  D R Ciocca; E H Luque
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

3.  Analysis of estrogen receptors in human breast cancer by assays using monoclonal antibodies and by the dextran-coated charcoal method.

Authors:  N Fujino; K Sakamoto; N Shigaki; J Yamashita; M Kimura; M Akagi
Journal:  Jpn J Surg       Date:  1987-09

4.  Expression of complement regulating factors in gastric cancer cells.

Authors:  T Inoue; M Yamakawa; T Takahashi
Journal:  Mol Pathol       Date:  2002-06

5.  Effects of estrogens on the testis of transsexuals: a pathological and immunocytochemical study.

Authors:  A Sapino; A Pagani; A Godano; G Bussolati
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Immunohistochemical detection of oestrogen receptor-related protein (p29) in apocrine glands.

Authors:  T Yamamura; T Honda; K Yoshikawa; K Aozasa
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Xing Huang; Wei Yan; Zheng-Xiang Song; Rong-Yu Qian; Ping Chen; Eeva Salminen; Jorma Toppari
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

8.  Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.

Authors:  Katsuyoshi Ishihama; Mitsunori Yamakawa; Shuho Semba; Hiroaki Takeda; Sumio Kawata; Seishi Kimura; Wataru Kimura
Journal:  J Clin Pathol       Date:  2007-08-24       Impact factor: 3.411

9.  Oestrogen retards the development of spontaneous thymomas in BUF/Mna rats.

Authors:  T Ezaki; H Fujii; K Matsuno; R Kawatsu; M Kotani
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.

Authors:  A Girling; M Caleffi; R J King; R R Millis
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.